InnoCore Pharmaceuticals is excited to attend Bio-Europe Spring, 2026, where you can connect with our team to explore our cutting-edge solutions to advance your API into a long-acting injectable.
Vincent de Boer, Business Development Manager, and Martin Bakker, Chief Business Officer, will be on site to discuss how our SynBiosys® polymer platform enables the development of biodegradable long-acting injectables—without the typical limitations of aggregation, acylation, or high local pH.
Whether you’re aiming to reduce dosing frequency or transition from IV to subQ administration, our technology offers tailored, tunable release profiles for peptides, proteins, and other biologics.
We would love to discuss how our drug delivery technologies can support your development goals. You can connect with Martin or Vincent through the Bio-Europe partnering platform or reach out to us directly via the contact form below.